Detalhe da pesquisa
1.
Antibody response to three-dose anti-SARS-CoV-2 mRNA-vaccination in treated solid cancer patients.
Int J Cancer
; 154(8): 1371-1376, 2024 Apr 15.
Artigo
Inglês
| MEDLINE | ID: mdl-38100252
2.
Immunogenicity of two doses of BNT162b2 and mRNA-1273 vaccines for solid cancer patients on treatment with or without a previous SARS-CoV-2 infection.
Int J Cancer
; 152(4): 661-671, 2023 02 15.
Artigo
Inglês
| MEDLINE | ID: mdl-36056571
3.
Genome-wide epigenetic and mRNA-expression profiling followed by CRISPR/Cas9-mediated gene-disruptions corroborate the MIR141/MIR200C-ZEB1/ZEB2-FGFR1 axis in acquired EMT-associated EGFR TKI-resistance in NSCLC cells.
Transl Lung Cancer Res
; 12(1): 42-65, 2023 Jan 31.
Artigo
Inglês
| MEDLINE | ID: mdl-36762066